Literature DB >> 21212064

Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing.

Michael J Hall1, Sharon L Manne, Gary Winkel, Daniel S Chung, David S Weinberg, Neal J Meropol.   

Abstract

BACKGROUND: Decision support to facilitate informed consent is increasingly important for complicated medical tests. Here, we test a theoretical model of factors influencing decisional conflict in a study examining the effects of a decision support aid that was designed to assist patients at high risk for hereditary nonpolyposis colorectal cancer (CRC) deciding whether to pursue the microsatellite instability (MSI) test.
METHODS: Participants were 239 CRC patients at high familial risk for a genetic mutation who completed surveys before and after exposure to the intervention. Half of the sample was assigned to the CD-ROM aid and half received a brief description of the test. Structural equation modeling was employed to examine associations among the intervention, knowledge, pros and cons to having MSI testing, self-efficacy, preparedness, and decisional conflict.
RESULTS: The goodness of fit for the model was acceptable [FIML, full information maximum likelihood, χ(2) (df = 280) = 392.24; P = 0.00]. As expected, the paths to decisional conflict were significant for postintervention pros of MSI testing (t = -2.43; P < 0.05), cons of MSI testing (t = 2.78; P < 0.05), and preparedness (t = -7.27; P < 0.01). The intervention impacted decisional conflict by increasing knowledge about the MSI test and knowledge exerted its effects on decisional conflict by increasing preparedness to make a decision about the test and by increases in perceived benefits of having the test.
CONCLUSION: Increasing knowledge, preparedness, and perceived benefits of undergoing the MSI test facilitate informed decision making for this test. IMPACT: Understanding mechanisms underlying health decisions is critical for improving decisional support. Individuals with Lynch syndrome have an elevated lifetime risk of CRC. Risk of Lynch syndrome may be assessed with a tumor-based screening test (MSI testing or immunohistochemical tissue staining). ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21212064      PMCID: PMC3076798          DOI: 10.1158/1055-9965.EPI-10-0685

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  A tailored intervention to aid decision-making about hormone replacement therapy.

Authors:  Colleen M McBride; Lori A Bastian; Susan Halabi; Laura Fish; Isaac M Lipkus; Hayden B Bosworth; Barbara K Rimer; Ilene C Siegler
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

2.  Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.

Authors:  Julien Mancini; Catherine Noguès; Claude Adenis; Pascaline Berthet; Valerie Bonadona; Agnès Chompret; Isabelle Coupier; François Eisinger; Jean-Pierre Fricker; Marion Gauthier-Villars; Christine Lasset; Alain Lortholary; Tan Dat N'Guyen; Philippe Vennin; Hagay Sobol; Dominique Stoppa-Lyonnet; Claire Julian-Reynier
Journal:  Eur J Cancer       Date:  2006-03-23       Impact factor: 9.162

3.  Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.

Authors:  Sharon L Manne; Neal J Meropol; David S Weinberg; Hetal Vig; Zohra Ali-Khan Catts; Cheri Manning; Eric Ross; Kristen Shannon; Daniel C Chung
Journal:  J Clin Oncol       Date:  2010-02-08       Impact factor: 44.544

4.  Randomized controlled trial of a patient decision aid for colorectal cancer screening.

Authors:  James G Dolan; Susan Frisina
Journal:  Med Decis Making       Date:  2002 Mar-Apr       Impact factor: 2.583

5.  A decision aid for autologous pre-donation in cardiac surgery--a randomized trial.

Authors:  A Laupacis; A M O'Connor; E R Drake; F D Rubens; J A Robblee; F C Grant; P S Wells
Journal:  Patient Educ Couns       Date:  2005-07-15

6.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

7.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

8.  How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.

Authors:  Michael H Farrell; Margaret Ann Murphy; Carl E Schneider
Journal:  Eff Clin Pract       Date:  2002 May-Jun

9.  Influence of a patient decision aid on decisional conflict related to PSA testing: a structural equation model.

Authors:  Robert L Stephens; Ye Xu; Robert J Volk; Lawrence E Scholl; Stephanie L Kamin; E Wayne Holden; Leonardo A Stroud
Journal:  Health Psychol       Date:  2008-11       Impact factor: 4.267

Review 10.  Decision aids for people facing health treatment or screening decisions.

Authors:  A M O'Connor; D Stacey; V Entwistle; H Llewellyn-Thomas; D Rovner; M Holmes-Rovner; V Tait; J Tetroe; V Fiset; M Barry; J Jones
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  8 in total

1.  The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.

Authors:  Donna L Berry; Barbara Halpenny; Fangxin Hong; Seth Wolpin; William B Lober; Kenneth J Russell; William J Ellis; Usha Govindarajulu; Jaclyn Bosco; B Joyce Davison; Gerald Bennett; Martha K Terris; Andrea Barsevick; Daniel W Lin; Claire C Yang; Greg Swanson
Journal:  Urol Oncol       Date:  2011-12-07       Impact factor: 3.498

2.  Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices.

Authors:  Eric C Anderson; John DiPalazzo; Emily Edelman; Petra Helbig; Kate Reed; Susan Miesfeldt; Christian Thomas; F Lee Lucas; Anny T H R Fenton; Andrey Antov; Michael J Hall; J Scott Roberts; Jens Rueter; Paul K J Han
Journal:  JCO Precis Oncol       Date:  2021-09-29

Review 3.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

4.  The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial.

Authors:  S M Miller; S V Hudson; B L Egleston; S Manne; J S Buzaglo; K Devarajan; L Fleisher; J Millard; N Solarino; J Trinastic; N J Meropol
Journal:  Psychooncology       Date:  2012-02-14       Impact factor: 3.894

5.  Attitudes and Decisional Conflict Regarding Breast Reconstruction Among Breast Cancer Patients.

Authors:  Sharon L Manne; Neal Topham; Laurie Kirstein; Shannon Myers Virtue; Kristin Brill; Katie A Devine; Tina Gajda; Sara Frederick; Katie Darabos; Kristen Sorice
Journal:  Cancer Nurs       Date:  2016 Nov/Dec       Impact factor: 2.760

6.  Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study.

Authors:  Michael J Hall; Meagan M Herda; Elizabeth A Handorf; Christina C Rybak; Cindy A Keleher; Mark Siemon; Mary B Daly
Journal:  Genet Med       Date:  2014-05-01       Impact factor: 8.822

7.  Predictors of patient uptake of colorectal cancer gene environment risk assessment.

Authors:  Michael J Hall; Sharon L Manne; Ronald E Myers; Eileen M Keenan; Andrew M Balshem; David S Weinberg
Journal:  Genome Med       Date:  2012-11-29       Impact factor: 11.117

8.  Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials.

Authors:  Kimberly R Enard; Patricia Dolan Mullen; Geetanjali R Kamath; Nickell M Dixon; Robert J Volk
Journal:  BMC Med Inform Decis Mak       Date:  2016-06-06       Impact factor: 2.796

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.